Scalper1 News
SAN FRANCISCO — The JPMorgan Healthcare Conference continued to yield mixed results for investors in its second day Tuesday, as several companies tweaked their guidance and big pharmas offered incremental updates. Specialty drugmaker Horizon Pharma (HZNP) had the best day, as its shares rose 6.2%, to 19.21, after the company updated its guidance ahead of its presentation Wednesday. Horizon said in a press release that its buyout of Scalper1 News
Scalper1 News